NCT05568095Phase 3Completed

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

Study sponsor: Arcus Biosciences, Inc. · RCUS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-08-28Actual
Enrollment · participants1040Actual
Source updated2026-09-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2026. After: 28 Aug 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 1 field changed

Primary completion date changed

Before: Jun 2026. After: Aug 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview